EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TRIM28‐Derived Peptide Exerts Anti‐Tumor Roles by Stabilizing Tumor Suppressive BRD7 Protein in Multiple Cancers

Qingqing Wei iD, Changning Xue, Mengna Li, Jianxia Wei, Lemei Zheng, Shipeng Chen, Yijie Wang, Yumei Duan, Yanwei Luo iD, Wei Xiong iD, Ming Zhou iD

Advanced Science · 2026

DOI: 10.1002/advs.76974 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Qingqing Wei und 10 weiteren Autor:innen. Beteiligte Einrichtung: NHC Key Laboratory of Carcinogenesis, Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Sc…. Hauptthemen laut MEDLINE: Chromosomal Proteins, Non-Histone, Neoplasms, Peptides. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Key Project of Hunan Provincial Natural Science Foundation, Hunan Provincial Key Research and Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BRD7 serves as a critical tumor suppressor, yet it is frequently inactivated via ubiquitination‐mediated proteasomal degradation, facilitating tumor progression and metastasis. Although stabilizing or activating BRD7 represents a promising therapeutic strategy, pharmacological agents to achieve this remain limited. Here, we aimed to develop a peptide‐based approach to enhance BRD7 protein stability. We first mapped the TRIM28‐BRD7 interaction to the 299–349 aa region within the Coiled‐coil domain of TRIM28. Based on this interface, we designed two α‐helical peptides, TAB12 and TAB14, that mimic the key structural features. Mechanistically, TAB12 exhibits strong binding affinity toward BRD7 protein and competitively disrupts the TRIM28‐BRD7 interaction, thereby blocking TRIM28‐mediated BRD7 ubiquitination and stabilizing endogenous BRD7. In vitro functional assays demonstrated that TAB12 markedly inhibits tumor cell proliferation, migration, and invasion, induces cell apoptosis, and presents low cytotoxicity toward normal cells. Subsequent rescue experiments confirmed that BRD7 knockdown substantially abrogates the anti‐tumor effects of TAB12, verifying that TAB12's function depends on stabilizing BRD7. Furthermore, in vivo animal models validated that TAB12 significantly suppresses tumor growth with a favorable safety profile. Therefore, this study identifies a novel peptide agent that exerts broad anti‐tumor effects by stabilizing BRD7, offering a feasible strategy for restoring tumor suppressor function.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Chromosomal Proteins, Non-HistoneNeoplasmsPeptidesHumansBromodomain Containing ProteinsAnimalsMiceCell Line, TumorCell ProliferationApoptosisMice, Nude

Stichwörter der Autor:innen

BRD7TRIM28anti‐tumormultiple cancerspeptidetargeted therapy

Substanzen

Bromodomain Containing ProteinsBRD7 protein, humanChromosomal Proteins, Non-HistonePeptides

Autor:innen und Institutionen

  • NHC Key Laboratory of Carcinogenesis, Hunan Key Laboratory of Oncotarget Gene, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, China.
  • Cancer Research Institute and School of Basic Medical Sciences, Central South University, Changsha, China.
  • The Key Laboratory of Carcinogenesis and Cancer Invasion of the Chinese Ministry of Education, Central South University, Changsha, China.
  • Xiangya School of Medicine, Central South University, Changsha, China.
  • Department of Blood Transfusion, The Third Xiangya Hospital, Central South University, Changsha, Hunan, China.

ORCID-Profile: Qingqing Wei, Yanwei Luo, Wei Xiong, Ming Zhou

Förderung

  • National Natural Science Foundation of China
  • Key Project of Hunan Provincial Natural Science Foundation
  • Hunan Provincial Key Research and Development Program
  • Program of Introducing Talents of Discipline to Universities
  • Project 211

Zitieren

APA

Wei, Q., Xue, C., Li, M., Wei, J., Zheng, L., Chen, S., Wang, Y., Duan, Y., Luo, Y., Xiong, W., & Zhou, M. (2026). TRIM28‐Derived Peptide Exerts Anti‐Tumor Roles by Stabilizing Tumor Suppressive BRD7 Protein in Multiple Cancers. Advanced Science. https://doi.org/10.1002/advs.76974

Vancouver

Wei Q, Xue C, Li M, Wei J, Zheng L, Chen S, et al. TRIM28‐Derived Peptide Exerts Anti‐Tumor Roles by Stabilizing Tumor Suppressive BRD7 Protein in Multiple Cancers. Advanced Science. 2026. doi:10.1002/advs.76974

BibTeX
@article{Wei2026,
  author = {Wei, Qingqing and Xue, Changning and Li, Mengna and Wei, Jianxia and Zheng, Lemei and Chen, Shipeng and Wang, Yijie and Duan, Yumei and Luo, Yanwei and Xiong, Wei and Zhou, Ming},
  title = {TRIM28‐Derived Peptide Exerts Anti‐Tumor Roles by Stabilizing Tumor Suppressive BRD7 Protein in Multiple Cancers},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.76974}
}
Kostenlos starten →